Other Titles
Symposium: Meta-analyses of human genome studies: Epigenetic risk factors and population health issues in the world
Abstract
Session presented on Monday, July 28, 2014: Purpose: The purpose of this presentation is to disseminate current evidence on population genome health, through the meta-analyses of epigenetic risk factors, for cardiovascular (CV) health. CV Disease (CVD) continues to be the leading cause of death worldwide. Studies have associated Apolipoprotein A5 (APOA5, 1131T>C, rs662799) gene polymorphism with plasma triglyceride levels for CVD. Life style risk factors such as smoking, alcohol intake, and physical inactivity were associated with increased risks for CVD. Methods: Literature searches, quality scores, and inter-rater evaluation on data coding were completed to ensure data accuracy for pooled meta-analyses. Results: Preliminary analyses included 11,340 CVD cases and 18,758 controls from 37 studies. The gene mutation variations (TC and CC subtypes) in Asian populations were higher (53.1-42.4%) than Caucasian populations (21.4-10.2%) across the world, for control and case groups. For validation, pollution indicators were checked and shown worse in Asia than other countries. For lifestyle related meta-analyses, smoking was associated with an increased risk of CVD (18 studies, 5,035 cases, 9,140 controls, RR=1.70, 95% Confidence Interval = 1.39-2.08, p < 0.0001). However, alcohol intake (5 studies, 1,646 cases, 3094 controls, RR=1.42, 0.86-2.34) and physical inactivity (4 studies, 466 cases, 1,005 controls, RR=0.91, 0.74-1.13) were not significant for pooled meta-analyses. Conclusion: For association of APOA5 gene variations, genotype TT (61.1% cases, 69.9% controls) was protective against CVD for all populations combined (RR = 0.78, 0.74-0.83, p < 0.0001). APOA5 is a key gene for triglyceride metabolism to reduce inflammation for epigenetics in the methylation pathways. Future studies are needed to examine epigenetic factors for population health associated with APOA5 gene variations in the prevention of CVD.
Sigma Membership
Iota Sigma
Type
Presentation
Format Type
Text-based Document
Study Design/Type
N/A
Research Approach
N/A
Keywords:
Cardiovascular-Health, Meta-Analyses, Epigenetics
Recommended Citation
Lin, Yen-Chiun; Nunez, Veronica; and Shiao, Shyang-Yun Pamela K., "Meta-analyses of epigenetics risk factors for cardiovascular health: APOA5 human gene variations across different race-ethnicity groups" (2014). INRC (Congress). 145.
https://www.sigmarepository.org/inrc/2014/presentations_2014/145
Conference Name
25th International Nursing Research Congress
Conference Host
Sigma Theta Tau International
Conference Location
Hong Kong
Conference Year
2014
Rights Holder
All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.
All permission requests should be directed accordingly and not to the Sigma Repository.
All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.
Review Type
Abstract Review Only: Reviewed by Event Host
Acquisition
Proxy-submission
Meta-analyses of epigenetics risk factors for cardiovascular health: APOA5 human gene variations across different race-ethnicity groups
Hong Kong
Session presented on Monday, July 28, 2014: Purpose: The purpose of this presentation is to disseminate current evidence on population genome health, through the meta-analyses of epigenetic risk factors, for cardiovascular (CV) health. CV Disease (CVD) continues to be the leading cause of death worldwide. Studies have associated Apolipoprotein A5 (APOA5, 1131T>C, rs662799) gene polymorphism with plasma triglyceride levels for CVD. Life style risk factors such as smoking, alcohol intake, and physical inactivity were associated with increased risks for CVD. Methods: Literature searches, quality scores, and inter-rater evaluation on data coding were completed to ensure data accuracy for pooled meta-analyses. Results: Preliminary analyses included 11,340 CVD cases and 18,758 controls from 37 studies. The gene mutation variations (TC and CC subtypes) in Asian populations were higher (53.1-42.4%) than Caucasian populations (21.4-10.2%) across the world, for control and case groups. For validation, pollution indicators were checked and shown worse in Asia than other countries. For lifestyle related meta-analyses, smoking was associated with an increased risk of CVD (18 studies, 5,035 cases, 9,140 controls, RR=1.70, 95% Confidence Interval = 1.39-2.08, p < 0.0001). However, alcohol intake (5 studies, 1,646 cases, 3094 controls, RR=1.42, 0.86-2.34) and physical inactivity (4 studies, 466 cases, 1,005 controls, RR=0.91, 0.74-1.13) were not significant for pooled meta-analyses. Conclusion: For association of APOA5 gene variations, genotype TT (61.1% cases, 69.9% controls) was protective against CVD for all populations combined (RR = 0.78, 0.74-0.83, p < 0.0001). APOA5 is a key gene for triglyceride metabolism to reduce inflammation for epigenetics in the methylation pathways. Future studies are needed to examine epigenetic factors for population health associated with APOA5 gene variations in the prevention of CVD.